Alfredo Ponce‐de‐León

25.7k total citations · 1 hit paper
173 papers, 3.9k citations indexed

About

Alfredo Ponce‐de‐León is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Alfredo Ponce‐de‐León has authored 173 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Infectious Diseases, 87 papers in Epidemiology and 34 papers in Surgery. Recurrent topics in Alfredo Ponce‐de‐León's work include Tuberculosis Research and Epidemiology (52 papers), Mycobacterium research and diagnosis (36 papers) and Antifungal resistance and susceptibility (25 papers). Alfredo Ponce‐de‐León is often cited by papers focused on Tuberculosis Research and Epidemiology (52 papers), Mycobacterium research and diagnosis (36 papers) and Antifungal resistance and susceptibility (25 papers). Alfredo Ponce‐de‐León collaborates with scholars based in Mexico, United States and United Kingdom. Alfredo Ponce‐de‐León's co-authors include José Sifuentes‐Osornio, Miriam Bobadilla-del-Valle, Lourdes García‐García, Peter M. Small, Areli Martínez‐Gamboa, Leticia Ferreyra-Reyes, Luis Pablo Cruz‐Hervert, Pedro Torres‐González, María Fernanda González-Lara and María Eugenia Jiménez-Corona and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alfredo Ponce‐de‐León

163 papers receiving 3.8k citations

Hit Papers

Posaconazole versus voriconazole for primary treatment of... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfredo Ponce‐de‐León Mexico 35 2.8k 2.2k 1.0k 414 408 173 3.9k
José Sifuentes‐Osornio Mexico 38 3.0k 1.1× 2.6k 1.2× 1.0k 1.0× 404 1.0× 564 1.4× 212 4.8k
Roberto Luzzati Italy 33 1.9k 0.7× 1.5k 0.7× 478 0.5× 470 1.1× 350 0.9× 158 3.9k
Hsin‐Yun Sun Taiwan 39 2.7k 1.0× 3.2k 1.4× 697 0.7× 298 0.7× 468 1.1× 263 5.6k
Mohammad Javad Nasiri Iran 33 1.6k 0.6× 1.1k 0.5× 554 0.5× 727 1.8× 407 1.0× 190 3.3k
Robert Krause Austria 41 3.2k 1.1× 3.0k 1.3× 328 0.3× 647 1.6× 309 0.8× 164 5.4k
Amita Jain India 37 2.0k 0.7× 1.5k 0.7× 748 0.7× 667 1.6× 261 0.6× 214 4.2k
George Alangaden United States 34 2.5k 0.9× 2.2k 1.0× 431 0.4× 426 1.0× 401 1.0× 129 4.3k
Sook‐In Jung South Korea 30 1.8k 0.6× 1.2k 0.5× 272 0.3× 334 0.8× 586 1.4× 166 3.5k
Emanuele Durante‐Mangoni Italy 35 1.2k 0.4× 2.3k 1.1× 533 0.5× 376 0.9× 1.2k 2.9× 145 4.3k
Mario Cruciani Italy 39 2.4k 0.8× 1.9k 0.9× 623 0.6× 282 0.7× 192 0.5× 156 4.7k

Countries citing papers authored by Alfredo Ponce‐de‐León

Since Specialization
Citations

This map shows the geographic impact of Alfredo Ponce‐de‐León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Ponce‐de‐León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Ponce‐de‐León more than expected).

Fields of papers citing papers by Alfredo Ponce‐de‐León

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Ponce‐de‐León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Ponce‐de‐León. The network helps show where Alfredo Ponce‐de‐León may publish in the future.

Co-authorship network of co-authors of Alfredo Ponce‐de‐León

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Ponce‐de‐León. A scholar is included among the top collaborators of Alfredo Ponce‐de‐León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Ponce‐de‐León. Alfredo Ponce‐de‐León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González-Lara, María Fernanda, et al.. (2025). Comparison of the Filamentous Fungi Library v4.0 MALDI Biotyper Platform vs MSI-2 performance for identifying filamentous fungi from liquid cultures. Journal of Clinical Microbiology. 63(3). e0137124–e0137124.
2.
Román‐Montes, Carla M., et al.. (2025). Molecular Identification and Antifungal Susceptibility of Fusarium spp. Clinical Isolates. Mycoses. 68(1). e70012–e70012. 1 indexed citations
3.
Rajme‐López, Sandra, Carla M. Román‐Montes, Eric Ochoa‐Hein, et al.. (2025). Recommended antibiotic treatment agreement between infectious diseases specialists and ChatGPT®. BMC Infectious Diseases. 25(1). 38–38. 4 indexed citations
4.
Rajme‐López, Sandra, Edgar Ortíz‐Brizuela, Karla M. Tamez‐Torres, et al.. (2024). Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia. Cancer Reports. 7(8). e2129–e2129. 1 indexed citations
5.
Martínez-Guerra, Bernardo Alfonso, Karla M. Tamez‐Torres, Carla M. Román‐Montes, et al.. (2023). Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria. Antibiotics. 12(7). 1130–1130. 5 indexed citations
6.
Román‐Montes, Carla M., Bernardo Alfonso Martínez-Guerra, Sandra Rajme‐López, et al.. (2023). Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico. Journal of Fungi. 9(5). 583–583. 6 indexed citations
9.
Páez-Franco, José C., José Luis Maravillas‐Montero, Nancy R. Mejía‐Domínguez, et al.. (2022). Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology. PLoS ONE. 17(9). e0274910–e0274910. 15 indexed citations
10.
Olivas‐Martínez, Antonio, José Víctor Jiménez, Oscar Arturo Lozano-Cruz, et al.. (2021). In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS ONE. 16(2). e0245772–e0245772. 84 indexed citations
11.
Ponce‐de‐León, Alfredo, et al.. (2021). Genetic diversity of Mycobacterium bovis evaluated by spoligotyping and MIRU‐VNTR in an intensive dairy cattle breeding area in Mexico. Transboundary and Emerging Diseases. 69(3). 1144–1154.
12.
Martínez-Guerra, Bernardo Alfonso, María Fernanda González-Lara, Carla M. Román‐Montes, et al.. (2021). Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study. Emerging Microbes & Infections. 11(1). 50–59. 17 indexed citations
13.
Bello‐Chavolla, Omar Yaxmehen, Neftalí Eduardo Antonio-Villa, Edgar Ortíz‐Brizuela, et al.. (2020). Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score. PLoS ONE. 15(12). e0244051–e0244051. 16 indexed citations
14.
García‐García, Lourdes, Claudia Rangel‐Escareño, Leticia Ferreyra-Reyes, et al.. (2019). Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid. Journal of Immunology Research. 2019. 1–13. 18 indexed citations
15.
Torres‐González, Pedro, et al.. (2018). Potential Effect of Statins onMycobacterium tuberculosisInfection. Journal of Immunology Research. 2018. 1–14. 18 indexed citations
16.
Torres‐González, Pedro, Edgar Ortíz‐Brizuela, Miguel E. Cervera-Hernandez, et al.. (2016). Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case–control-control study. Diagnostic Microbiology and Infectious Disease. 86(2). 243–248. 7 indexed citations
17.
Camacho-Ortíz, Adrián, et al.. (2009). Factores asociados con el desarrollo de la enfermedad por Clostridium difficile en un hospital de tercer nivel en México: estudio de casos y controles. Revista de investigaci�n Cl�nica. 61(5). 371–377. 1 indexed citations
18.
García‐García, Lourdes, et al.. (2001). Resistencia de Mycobacterium tuberculosis a los antimicrobianos en Orizaba, Veracruz. Implicaciones para el programa de prevención y control de la tuberculosis. Revista de investigaci�n Cl�nica. 53(4). 315–323. 3 indexed citations
19.
Ponce‐de‐León, Alfredo, et al.. (2001). Resistencia de Mycobacterium tuberculosis a los antimicrobianos en Orizaba, Veracruz. Revista de investigaci�n Cl�nica. 53(4). 315–323. 2 indexed citations
20.
Chin, Daniel P., Kathryn DeRiemer, Peter M. Small, et al.. (1998). Differences in Contributing Factors to Tuberculosis Incidence in U.S.-born and Foreign-born Persons. American Journal of Respiratory and Critical Care Medicine. 158(6). 1797–1803. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026